Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 37 | 2025 | 758 | 6.130 |
Why?
|
| Blood Pressure | 29 | 2025 | 896 | 3.790 |
Why?
|
| Blood Pressure Determination | 21 | 2025 | 69 | 3.540 |
Why?
|
| Antihypertensive Agents | 15 | 2025 | 262 | 2.370 |
Why?
|
| Body Height | 1 | 2025 | 107 | 0.880 |
Why?
|
| Hypotension | 1 | 2024 | 72 | 0.790 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 7 | 2025 | 36 | 0.730 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 394 | 0.620 |
Why?
|
| American Medical Association | 2 | 2020 | 17 | 0.550 |
Why?
|
| Quality Improvement | 5 | 2023 | 485 | 0.530 |
Why?
|
| United States | 16 | 2025 | 7642 | 0.520 |
Why?
|
| Students, Medical | 2 | 2025 | 435 | 0.510 |
Why?
|
| Primary Health Care | 3 | 2018 | 379 | 0.450 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 1865 | 0.400 |
Why?
|
| Sphygmomanometers | 3 | 2022 | 5 | 0.390 |
Why?
|
| Nutrition Surveys | 4 | 2025 | 125 | 0.350 |
Why?
|
| Aged | 13 | 2025 | 20472 | 0.340 |
Why?
|
| Humans | 39 | 2025 | 93613 | 0.330 |
Why?
|
| Adult | 15 | 2025 | 27949 | 0.290 |
Why?
|
| Female | 18 | 2025 | 48781 | 0.240 |
Why?
|
| Clinical Competence | 2 | 2025 | 821 | 0.240 |
Why?
|
| Male | 15 | 2025 | 44582 | 0.240 |
Why?
|
| Middle Aged | 12 | 2025 | 27623 | 0.230 |
Why?
|
| Observational Studies as Topic | 1 | 2024 | 55 | 0.200 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 498 | 0.200 |
Why?
|
| Sex Factors | 1 | 2025 | 1104 | 0.180 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2021 | 38 | 0.180 |
Why?
|
| Young Adult | 4 | 2025 | 6937 | 0.170 |
Why?
|
| Health Services Accessibility | 3 | 2021 | 489 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 97 | 0.170 |
Why?
|
| Mobile Applications | 1 | 2022 | 78 | 0.170 |
Why?
|
| Benchmarking | 1 | 2021 | 80 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 112 | 0.170 |
Why?
|
| Self Care | 1 | 2021 | 167 | 0.160 |
Why?
|
| Patient Generated Health Data | 1 | 2019 | 2 | 0.160 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 108 | 0.150 |
Why?
|
| Racism | 1 | 2021 | 104 | 0.150 |
Why?
|
| Medicare | 1 | 2022 | 455 | 0.150 |
Why?
|
| Algorithms | 2 | 2019 | 1956 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 6 | 2021 | 1055 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2019 | 237 | 0.140 |
Why?
|
| American Heart Association | 3 | 2023 | 106 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 7072 | 0.130 |
Why?
|
| Public Health Practice | 1 | 2016 | 11 | 0.130 |
Why?
|
| Patient Care | 1 | 2018 | 97 | 0.120 |
Why?
|
| Telemedicine | 1 | 2020 | 226 | 0.120 |
Why?
|
| Blood Pressure Monitors | 1 | 2016 | 9 | 0.120 |
Why?
|
| International Agencies | 1 | 2016 | 34 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 256 | 0.120 |
Why?
|
| Marketing | 1 | 2016 | 23 | 0.120 |
Why?
|
| Biomedical Research | 2 | 2019 | 434 | 0.110 |
Why?
|
| Health Equity | 1 | 2018 | 102 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2020 | 374 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2017 | 298 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 3 | 2022 | 494 | 0.100 |
Why?
|
| Education, Medical | 1 | 2017 | 228 | 0.100 |
Why?
|
| Prevalence | 3 | 2025 | 1322 | 0.100 |
Why?
|
| Curriculum | 1 | 2017 | 594 | 0.090 |
Why?
|
| Adolescent | 3 | 2025 | 9612 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 755 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2025 | 1715 | 0.070 |
Why?
|
| Needs Assessment | 2 | 2021 | 172 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2718 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2018 | 917 | 0.060 |
Why?
|
| Emergency Shelter | 1 | 2022 | 2 | 0.050 |
Why?
|
| Safety-net Providers | 1 | 2023 | 45 | 0.050 |
Why?
|
| Reimbursement, Incentive | 1 | 2022 | 36 | 0.050 |
Why?
|
| Smartphone | 1 | 2022 | 52 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2022 | 120 | 0.040 |
Why?
|
| Seasons | 1 | 2023 | 240 | 0.040 |
Why?
|
| Temperature | 1 | 2023 | 423 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 46 | 0.040 |
Why?
|
| Models, Economic | 1 | 2021 | 62 | 0.040 |
Why?
|
| Age Factors | 1 | 2025 | 1907 | 0.040 |
Why?
|
| Data Warehousing | 1 | 2020 | 4 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 23 | 0.040 |
Why?
|
| Comorbidity | 1 | 2024 | 1007 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 329 | 0.040 |
Why?
|
| Auscultation | 1 | 2019 | 5 | 0.040 |
Why?
|
| Data Mining | 1 | 2020 | 44 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2025 | 9110 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2025 | 10185 | 0.040 |
Why?
|
| Data Accuracy | 1 | 2019 | 32 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 57 | 0.040 |
Why?
|
| Arm | 1 | 2019 | 97 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 105 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2020 | 214 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 630 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 219 | 0.030 |
Why?
|
| Health Policy | 1 | 2020 | 207 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 3837 | 0.030 |
Why?
|
| Medically Underserved Area | 1 | 2018 | 26 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 283 | 0.030 |
Why?
|
| Dental Care for Chronically Ill | 1 | 1997 | 4 | 0.030 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 1997 | 4 | 0.030 |
Why?
|
| Dental Caries | 1 | 1997 | 4 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1924 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 875 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 51 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 100 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 5406 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 174 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 206 | 0.030 |
Why?
|
| Organizations | 1 | 2016 | 17 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 920 | 0.030 |
Why?
|
| Government Regulation | 1 | 2016 | 49 | 0.030 |
Why?
|
| Medicaid | 1 | 2018 | 259 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 359 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 453 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 577 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 559 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1919 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5914 | 0.020 |
Why?
|
| Anesthesia, Dental | 1 | 1997 | 4 | 0.010 |
Why?
|
| Acidosis, Respiratory | 1 | 1997 | 7 | 0.010 |
Why?
|
| Acidosis, Lactic | 1 | 1997 | 10 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1997 | 131 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 1997 | 113 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 1997 | 128 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1997 | 195 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1997 | 3833 | 0.000 |
Why?
|